JIN-LONG CHEN - 03 Jun 2021 Form 4 Insider Report for NGM BIOPHARMACEUTICALS INC

Role
Chief Scientific Officer, Director
Signature
/s/ Jin-Long Chen
Issuer symbol
N/A
Transactions as of
03 Jun 2021
Net transactions value
+$99,999
Form type
4
Filing time
07 Jun 2021, 16:49:41 UTC
Next filing
29 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NGM Common Stock Options Exercise $99,999 +69,444 +7.5% $1.44 989,449 03 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGM Stock Option (Right to Buy) Options Exercise $0 -69,444 -100% $0.000000* 0 03 Jun 2021 Common Stock 69,444 $1.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested.